GlassScriptPhysician profile
Kevin David Rabie
NPI 1245694488
$17,712.69
in general payments reported to CMS, 2019-2025
40 companies · $3,112 in 2025
The $3,112 reported for 2025 was more than what 94% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,524 · 2020: $792 · 2021: $1,699 · 2022: $2,280 · 2023: $2,959 · 2024: $4,346 · 2025: $3,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,059 · Travel and Lodging: $2,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,059.09 |
| Travel and Lodging | $2,359.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,241.36 | 2019-2025 | Citrefix, Viaflow, Augment Injectable |
| Medline Industries LP | $1,964.98 | 2024 | |
| Linvatec Corporation | $1,239.44 | 2023-2025 | Biobrace 23mm, Quantum, Allograft Tissue |
| Kerecis Limited | $1,018.82 | 2020-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $898.76 | 2020-2025 | Grafix Pl, Stravix, Stravix Pl |
| Medtronic, INC. | $766.91 | 2024-2025 | Intellis Adaptivestim, Inceptiv, Venaseal |
| In2bones USA, LLC | $761.78 | 2021-2022 | |
| International Life Sciences | $522.52 | 2023 | |
| Lifenet Health | $429.04 | 2023-2025 | Theragenesis Wound Matrix |
| Bioventus LLC | $359.84 | 2021-2025 | Stimrouter Implantable Kit, Exogen Ultrasound Bone Healing System |
| Fortis Surgical, LLC | $273.16 | 2023-2025 | |
| Convatec INC. | $270.47 | 2023-2025 | |
| Horizon Therapeutics Plc | $250.85 | 2023 | Krystexxa |
| Misonix INC | $212.68 | 2019-2020 | |
| Integra Lifesciences Corporation | $190.48 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $183.69 | 2021-2025 | Nuzyra |
| Sanara Medtech INC. | $168.62 | 2023-2025 | Celleraterx, Celleraterx |
| Paragon 28, INC. | $166.25 | 2019-2022 | |
| Ossio INC | $155.30 | 2022 | |
| Biocomposites INC | $149.41 | 2023 | Stimulan |
| Organogenesis INC. | $148.13 | 2019-2025 | Puraply Wound Matrix |
| Heron Therapeutics, INC. | $132.60 | 2022 | |
| Trice Medical, INC. | $130.14 | 2025 | |
| Innovation Technologies INC | $127.38 | 2025 | Irrisept |
| Anika Therapeutics, INC. | $126.78 | 2023 | Toe Motion, Tactoset, Twist |
| Orthofix Medical, INC. | $124.69 | 2019 | |
| Treace Medical Concepts, INC. | $106.48 | 2025 | |
| Amniox Medical, INC. | $99.84 | 2019 | |
| Medela LLC | $80.72 | 2021-2022 | |
| Depuy Synthes Sales INC. | $63.07 | 2023 | Na, Hammerlock, Motoband |
| Flower Orthopedics Coporation | $58.10 | 2023 | |
| Alfasigma USA, INC. | $53.62 | 2021-2022 | |
| Amgen INC. | $50.65 | 2024 | Krystexxa |
| Next Science LLC | $45.24 | 2023 | Xperience, Blastx, Surgx |
| Nevro Corp. | $38.19 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $29.03 | 2022-2023 | Seglentis |
| Acell, INC. | $22.25 | 2020 | |
| Abbvie INC. | $21.51 | 2022 | |
| Fidia Pharma USA INC. | $15.32 | 2022 | |
| Abbott Laboratories | $14.59 | 2023 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Rabie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.